IRCCS Istituto Oncologico Europeo

Milan 20141

1 studies enrolling now · 3 studies all time

What they study most

Extensive Stage Small-cell Lung Cancer, Extensive-Stage Small-Cell Lung Cancer, Limited Stage Small Cell Lung Cancer, Small Cell Lung Cancer, Small-Cell Lung Cancer, Small-cell Lung Cancer

Studies at this site

• A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC) — Recruiting now
• Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC) — Running, not enrolling
• Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab — Running, not enrolling